EDWARDS JAMES MICHAEL (Chief Financial Officer) received a stock award from BIOAFFINITY TECHNOLOGIES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/14/2025ACC: 0001493152-25-002146
Officer· Chief Financial Officer
Since Aug 2022
+6.17K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
6.17K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.17K
Price / share
—
Trade value
—
% of position
5.4%
1/10/2025
113.96K→120.13K
Total
Net shares
+6.17K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/10/2025 | A · Award | +6.17K | — | — | 5.4% | 113.96K | 120.13K |
| Total | +6.17K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported